[ad_1] AbbVie Inc. ABBV, +1.94% on Friday reported fourth-quarter sales that topped analysts’ estimates, even…
Tag:
Biopharmaceuticals
-
-
STOCK MARKET
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
by userby user[ad_1] UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of…
-
STOCK MARKET
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
by userby user[ad_1] Nvidia Corp. NVDA, +4.88% is doubling down on artificial-intelligence-powered drug discovery and development, announcing…
-
STOCK MARKET
Fusion Pharma climbs as radiopharmaceutical company flagged as potential merger target
by userby user[ad_1] Fusion Pharmaceuticals Inc.’s stock was up by 5.3% in premarket trading on Wednesday, as…
-
STOCK MARKET
Karuna Therapeutics’ stock hits record territory after Bristol Myers’ $14 billion buyout deal
by userby user[ad_1] Shares of Karuna Therapeutics Inc. KRTX, +47.29% rocketed 48% into record territory in premarket…
-
[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the…
-
STOCK MARKET
Panbela Therapeutics’ stock soars on positive FDA news on child cancer treatment
by userby user[ad_1] Shares of Panbela Therapeutics Inc. skyrocketed again Tuesday, following positive news from the U.S.…
-
STOCK MARKET
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
by userby user[ad_1] Crispr Therapeutics AG CRSP, -5.33% and Vertex Pharmaceuticals Inc. VRTX, -0.82% on Friday got…
-
STOCK MARKET
These advisers say markets are expecting unrealistic outcomes. Here are some alternatives.
by userby user[ad_1] Stocks are poised for an upbeat finish to the best month of gains for…
-
STOCK MARKET
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
by userby user[ad_1] Shares of Cabaletta Bio Inc. CABA, Gracell Biotechnologies Inc. GRCL and other smaller biotech…